The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when Efonidipine is combined with MAGNESIUM OXIDE.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when chloroquine is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when chloroquine is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when sevoflurane is combined with protriptyline.


The risk or severity of adverse effects can be increased when Melatonin is combined with Milnacipran.


The risk or severity of adverse effects can be increased when sevoflurane is combined with cetirizine.


The risk or severity of adverse effects can be increased when meperidine is combined with dibucaine.


The risk or severity of adverse effects can be increased when halothane is combined with Olmesartan.


The risk or severity of adverse effects can be increased when apomorphine is combined with bromocriptine.


The risk or severity of adverse effects can be increased when apomorphine is combined with ropinirole.


The risk or severity of adverse effects can be increased when tenoxicam is combined with suprofen.


The risk or severity of adverse effects can be increased when tenoxicam is combined with loteprednol.


The risk or severity of adverse effects can be increased when halothane is combined with topiramate.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when tiapride is combined with Iloperidone.


The risk or severity of adverse effects can be increased when carbamazepine is combined with Fospropofol.


The risk or severity of adverse effects can be increased when levorphanol is combined with PAMABROM.


The risk or severity of adverse effects can be increased when Butethal is combined with METAXALONE.


The risk or severity of adverse effects can be increased when tenoxicam is combined with niflumic acid.


The risk or severity of adverse effects can be increased when meprobamate is combined with tetracaine.


The risk or severity of adverse effects can be increased when formestane is combined with Pefloxacin.


The risk or severity of adverse effects can be increased when CYCLIZINE is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when formestane is combined with GALLAMINE TRIETHIODIDE.


The risk or severity of adverse effects can be increased when scopolamine is combined with sertraline.


The risk or severity of adverse effects can be increased when ketoprofen is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when sevoflurane is combined with fludiazepam.


The risk or severity of adverse effects can be increased when oxaprozin is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when valsartan is combined with Olopatadine.


The risk or severity of adverse effects can be increased when oxaprozin is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when Eprosartan is combined with trandolapril.


The risk or severity of adverse effects can be increased when oxaprozin is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when ketorolac is combined with prednisone.


The risk or severity of adverse effects can be increased when gabapentin is combined with zopiclone.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with Telmisartan.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with apraclonidine.


The risk or severity of adverse effects can be increased when ramipril is combined with meclofenamic acid.


The risk or severity of adverse effects can be increased when quetiapine is combined with Aliskiren.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with alclofenac.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with methyldopa.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when Eplerenone is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when epirizole is combined with Clobetasone.


The risk or severity of adverse effects can be increased when ethopropazine is combined with PIPECURONIUM.


The risk or severity of adverse effects can be increased when ethopropazine is combined with Vecuronium.


The risk or severity of adverse effects can be increased when floctafenine is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when floctafenine is combined with flurbiprofen.


The risk or severity of adverse effects can be increased when irbesartan is combined with Naftifine.


The risk or severity of adverse effects can be increased when methylene blue is combined with dipivefrin.


The risk or severity of adverse effects can be increased when ethopropazine is combined with pancuronium.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when oxprenolol is combined with etizolam.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with butalbital.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when secobarbital is combined with oxycodone.


The risk or severity of adverse effects can be increased when brotizolam is combined with fexofenadine.


The risk or severity of adverse effects can be increased when pentamidine is combined with felodipine.


The risk or severity of adverse effects can be increased when apomorphine is combined with Nabilone.


The risk or severity of adverse effects can be increased when apomorphine is combined with brimonidine.


The risk or severity of adverse effects can be increased when MOXONIDINE is combined with ropinirole.


The risk or severity of adverse effects can be increased when pergolide is combined with Regorafenib.


The risk or severity of adverse effects can be increased when zaleplon is combined with methocarbamol.


The risk or severity of adverse effects can be increased when zaleplon is combined with triprolidine.


The risk or severity of adverse effects can be increased when TRIMETHAPHAN is combined with Propiverine.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with ZILEUTON.


The risk or severity of adverse effects can be increased when clorazepate is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when phenobarbital is combined with dibucaine.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with flunisolide.


The risk or severity of adverse effects can be increased when alprazolam is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when antipyrine is combined with alclofenac.


The risk or severity of adverse effects can be increased when medrysone is combined with Echothiophate.


The risk or severity of adverse effects can be increased when loxapine is combined with DESFLURANE.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with zonisamide.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with atenolol.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when Normethadone is combined with amoxapine.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with tiagabine.


The risk or severity of adverse effects can be increased when Normethadone is combined with nortriptyline.


The risk or severity of adverse effects can be increased when lidocaine is combined with meclizine.


The risk or severity of adverse effects can be increased when propranolol is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when AMILORIDE is combined with Metipranolol.


The risk or severity of adverse effects can be increased when temazepam is combined with amisulpride.


The risk or severity of adverse effects can be increased when EDOXABAN is combined with Nintedanib.


The risk or severity of adverse effects can be increased when clozapine is combined with butamben.


The risk or severity of adverse effects can be increased when chloroxine is combined with flunarizine.


The risk or severity of adverse effects can be increased when CARTEOLOL is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when ketorolac is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when Pramocaine is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when ketorolac is combined with celecoxib.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when Calcium phosphate is combined with Paricalcitol.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with equilin.


The risk or severity of adverse effects can be increased when nicergoline is combined with lidocaine.


The risk or severity of adverse effects can be increased when hyoscyamine is combined with Pentolinium.


The risk or severity of adverse effects can be increased when Paliperidone is combined with Pramocaine.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when Butethal is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when Paliperidone is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when epirizole is combined with desoximetasone.


The risk or severity of adverse effects can be increased when Tedizolid phosphate is combined with Ziprasidone.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with nimesulide.


The risk or severity of adverse effects can be increased when ibudilast is combined with TROLAMINE SALICYLATE.


The risk or severity of adverse effects can be increased when tolazoline is combined with methazolamide.


The risk or severity of adverse effects can be increased when oxaprozin is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when ketamine is combined with topiramate.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with ethosuximide.


The risk or severity of adverse effects can be increased when codeine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when doxepin is combined with rasagiline.


The risk or severity of adverse effects can be increased when doxepin is combined with PROCATEROL.


The risk or severity of adverse effects can be increased when codeine is combined with pimozide.


The risk or severity of adverse effects can be increased when trandolapril is combined with nicardipine.


The risk or severity of adverse effects can be increased when codeine is combined with cyclothiazide.


The risk or severity of adverse effects can be increased when glutethimide is combined with tizanidine.


The risk or severity of adverse effects can be increased when thioridazine is combined with HEROIN.


The risk or severity of adverse effects can be increased when oxycodone is combined with brotizolam.


The risk or severity of adverse effects can be increased when oxycodone is combined with Canrenoic acid.


The risk or severity of adverse effects can be increased when Almotriptan is combined with ACETOPHENAZINE.


The risk or severity of adverse effects can be increased when thioridazine is combined with Nitroprusside.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with Spirapril.


The risk or severity of adverse effects can be increased when secobarbital is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when BECLOMETHASONE DIPROPIONATE is combined with Demecarium.


The risk or severity of adverse effects can be increased when methadone is combined with methazolamide.


The risk or severity of adverse effects can be increased when thioridazine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with cilazapril.


The risk or severity of adverse effects can be increased when epirizole is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when nisoldipine is combined with MAGNESIUM OXIDE.


The risk or severity of adverse effects can be increased when Tolcapone is combined with Eprosartan.


The risk or severity of adverse effects can be increased when selegiline is combined with promazine.


The risk or severity of adverse effects can be increased when selegiline is combined with spironolactone.


The risk or severity of adverse effects can be increased when pentazocine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with dibucaine.


The risk or severity of adverse effects can be increased when valsartan is combined with apraclonidine.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with METAXALONE.


The risk or severity of adverse effects can be increased when oxazepam is combined with methocarbamol.


The risk or severity of adverse effects can be increased when tretinoin is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when oxazepam is combined with triprolidine.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with valsartan.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with ramipril.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Difenoxin.


The risk or severity of adverse effects can be increased when azelastine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when triazolam is combined with nitrazepam.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with gemcitabine.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Epirubicin.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with teniposide.


The risk or severity of adverse effects can be increased when Nepafenac is combined with leflunomide.


The risk or severity of adverse effects can be increased when levorphanol is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when thiopental is combined with maprotiline.


The risk or severity of adverse effects can be increased when THYMOL is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when benzoic acid is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when methazolamide is combined with D-mannitol.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with ethosuximide.


The risk or severity of adverse effects can be increased when CYCLIZINE is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when oxprenolol is combined with tiapride.


The risk or severity of adverse effects can be increased when MORICIZINE is combined with fluvoxamine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with HYDROCODONE.


The risk or severity of adverse effects can be increased when captopril is combined with Lumiracoxib.


The risk or severity of adverse effects can be increased when Rufinamide is combined with fexofenadine.


The risk or severity of adverse effects can be increased when nitric oxide is combined with tretinoin.


The risk or severity of adverse effects can be increased when Fluprednidene is combined with physostigmine.


The risk or severity of adverse effects can be increased when Masoprocol is combined with fluocinonide.


The risk or severity of adverse effects can be increased when benzocaine is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when Fluprednidene is combined with rivastigmine.


The risk or severity of adverse effects can be increased when brotizolam is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when triflupromazine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when Fesoterodine is combined with Methylscopolamine bromide.


The risk or severity of adverse effects can be increased when isradipine is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when pentobarbital is combined with thiopental.


The risk or severity of adverse effects can be increased when bromazepam is combined with Asenapine.


The risk or severity of adverse effects can be increased when bifonazole is combined with felodipine.


The risk or severity of adverse effects can be increased when mesalamine is combined with DESONIDE.


The risk or severity of adverse effects can be increased when alprostadil is combined with mesalamine.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with mecamylamine.


The risk or severity of adverse effects can be increased when nefazodone is combined with toremifene.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with estrone.


The risk or severity of adverse effects can be increased when propranolol is combined with furosemide.


The risk or severity of adverse effects can be increased when Pomalidomide is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when ipratropium is combined with codeine.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when alclofenac is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when methadone is combined with atorvastatin.


The risk or severity of adverse effects can be increased when lithium ion is combined with Ramelteon.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with Tolcapone.


The risk or severity of adverse effects can be increased when lithium ion is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when trazodone is combined with Pizotifen.


The risk or severity of adverse effects can be increased when carvedilol is combined with Clevidipine.


The risk or severity of adverse effects can be increased when Articaine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with indomethacin.


The risk or severity of adverse effects can be increased when methadone is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when Perospirone is combined with tetracaine.


The risk or severity of adverse effects can be increased when Fluprednidene is combined with galanthamine.


The risk or severity of adverse effects can be increased when Fluprednidene is combined with Isoflurophate.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with nitrazepam.


The risk or severity of adverse effects can be increased when codeine is combined with Olopatadine.


The risk or severity of adverse effects can be increased when TETRABENAZINE is combined with quetiapine.


The risk or severity of adverse effects can be increased when olanzapine is combined with carbamazepine.


The risk or severity of adverse effects can be increased when ramipril is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when benzthiazide is combined with mecamylamine.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with butalbital.


The risk or severity of adverse effects can be increased when clemastine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Sodium phosphate monobasic.


The risk or severity of adverse effects can be increased when propofol is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with apraclonidine.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with mepivacaine.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with clidinium.


The risk or severity of adverse effects can be increased when Iloperidone is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Eprosartan is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when olanzapine is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when Eprosartan is combined with BALSALAZIDE.


The risk or severity of adverse effects can be increased when LISURIDE is combined with Sitaxsentan.


The risk or severity of adverse effects can be increased when propofol is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when tenoxicam is combined with sulfasalazine.


The risk or severity of adverse effects can be increased when biperiden is combined with propantheline.


The risk or severity of adverse effects can be increased when zopiclone is combined with triflupromazine.


The risk or severity of adverse effects can be increased when rizatriptan is combined with Lurasidone.


The risk or severity of adverse effects can be increased when Treprostinil is combined with salicylic acid.


The risk or severity of adverse effects can be increased when Remoxipride is combined with phenytoin.


The risk or severity of adverse effects can be increased when dantrolene is combined with Difenoxin.


The risk or severity of adverse effects can be increased when alprostadil is combined with diflunisal.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with azathioprine.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Methyl aminolevulinate.


The risk or severity of adverse effects can be increased when nalbuphine is combined with glutethimide.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with EXEMESTANE.


The risk or severity of adverse effects can be increased when triazolam is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when nifedipine is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when barnidipine is combined with phenoxybenzamine.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when ramipril is combined with trandolapril.


The risk or severity of adverse effects can be increased when Arotinolol is combined with Conivaptan.


The risk or severity of adverse effects can be increased when barnidipine is combined with LEVOSIMENDAN.


The risk or severity of adverse effects can be increased when ketoprofen is combined with Mometasone.


The risk or severity of adverse effects can be increased when nalbuphine is combined with scopolamine.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with formoterol.


The risk or severity of adverse effects can be increased when nalbuphine is combined with D-mannitol.


The risk or severity of adverse effects can be increased when midazolam is combined with zotepine.


The risk or severity of adverse effects can be increased when valsartan is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when Carbetocin is combined with Tolcapone.


The risk or severity of adverse effects can be increased when Carbetocin is combined with Nitroprusside.


The risk or severity of adverse effects can be increased when propoxyphene is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when reserpine is combined with dyclonine.


The risk or severity of adverse effects can be increased when reserpine is combined with propoxyphene.


The risk or severity of adverse effects can be increased when nabumetone is combined with Propacetamol.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with METAXALONE.


The risk or severity of adverse effects can be increased when oxprenolol is combined with Agomelatine.


The risk or severity of adverse effects can be increased when oxazepam is combined with Asenapine.


The risk or severity of adverse effects can be increased when Tramadol is combined with Halazepam.


The risk or severity of adverse effects can be increased when zopiclone is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when thiothixene is combined with meclizine.


The risk or severity of adverse effects can be increased when pirenzepine is combined with Mirabegron.


The risk or severity of adverse effects can be increased when LISURIDE is combined with ethanol.


The risk or severity of adverse effects can be increased when doxazosin is combined with Riociguat.


The risk or severity of adverse effects can be increased when quazepam is combined with zotepine.


The risk or severity of adverse effects can be increased when quazepam is combined with MELPERONE.


The risk or severity of adverse effects can be increased when buspirone is combined with Paliperidone.


The risk or severity of adverse effects can be increased when propranolol is combined with Nebivolol.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Drospirenone.


The risk or severity of adverse effects can be increased when Apremilast is combined with difluprednate.


The risk or severity of adverse effects can be increased when perphenazine is combined with mepivacaine.


The risk or severity of adverse effects can be increased when perphenazine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when Apremilast is combined with halcinonide.


The risk or severity of adverse effects can be increased when alprenolol is combined with floctafenine.


The risk or severity of adverse effects can be increased when diltiazem is combined with dipyridamole.


The risk or severity of adverse effects can be increased when reserpine is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when phenobarbital is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when sulpiride is combined with imipramine.


The risk or severity of adverse effects can be increased when oxycodone is combined with Desloratadine.


The risk or severity of adverse effects can be increased when Doxercalciferol is combined with Calcifediol.


The risk or severity of adverse effects can be increased when thioridazine is combined with MELPERONE.


The risk or severity of adverse effects can be increased when thioridazine is combined with zotepine.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when Spirapril is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with Halobetasol.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when efavirenz is combined with desipramine.


The risk or severity of adverse effects can be increased when pentobarbital is combined with Etomidate.


The risk or severity of adverse effects can be increased when terbinafine is combined with Pregabalin.


The risk or severity of adverse effects can be increased when Spirapril is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when Ramelteon is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with levodopa.


The risk or severity of adverse effects can be increased when ethopropazine is combined with meperidine.


The risk or severity of adverse effects can be increased when quinapril is combined with Sacubitril.


The risk or severity of adverse effects can be increased when hydromorphone is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with METAXALONE.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when Fluprednidene is combined with sparfloxacin.


The risk or severity of adverse effects can be increased when thioridazine is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when Rotigotine is combined with furosemide.


The risk or severity of adverse effects can be increased when Rotigotine is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when buspirone is combined with amisulpride.


The risk or severity of adverse effects can be increased when itraconazole is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with amisulpride.


The risk or severity of adverse effects can be increased when ISOSORBIDE MONONITRATE is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when Glycopyrronium is combined with oxymorphone.


The risk or severity of adverse effects can be increased when mebendazole is combined with metronidazole.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with butamben.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with protriptyline.


The risk or severity of adverse effects can be increased when RIMEXOLONE is combined with rivastigmine.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with cetirizine.


The risk or severity of adverse effects can be increased when barnidipine is combined with cilazapril.


The risk or severity of adverse effects can be increased when butamben is combined with duloxetine.


The risk or severity of adverse effects can be increased when ISOSORBIDE MONONITRATE is combined with Metipranolol.


The risk or severity of adverse effects can be increased when dichlorphenamide is combined with Aliskiren.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with Olopatadine.


The risk or severity of adverse effects can be increased when apomorphine is combined with Sacubitril.


The risk or severity of adverse effects can be increased when ramipril is combined with nadolol.


The risk or severity of adverse effects can be increased when Desloratadine is combined with duloxetine.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when tetracaine is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when Desloratadine is combined with fluoxetine.


The risk or severity of adverse effects can be increased when furosemide is combined with Amrubicin.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with betamethasone.


The risk or severity of adverse effects can be increased when barnidipine is combined with furosemide.


The risk or severity of adverse effects can be increased when barnidipine is combined with phentolamine.


The risk or severity of adverse effects can be increased when barnidipine is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when cocaine is combined with thiamylal.


The risk or severity of adverse effects can be increased when bromocriptine is combined with metoclopramide.


The risk or severity of adverse effects can be increased when Rufinamide is combined with fluvoxamine.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with acemetacin.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Olmesartan.


The risk or severity of adverse effects can be increased when morphine is combined with topiramate.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when morphine is combined with Olmesartan.


The risk or severity of adverse effects can be increased when HYDROCODONE is combined with trichlormethiazide.


The risk or severity of adverse effects can be increased when meprobamate is combined with Desloratadine.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with meclizine.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with risperidone.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with timolol.


The risk or severity of adverse effects can be increased when meprobamate is combined with zaleplon.


The risk or severity of adverse effects can be increased when meprobamate is combined with mepivacaine.


The risk or severity of adverse effects can be increased when butabarbital is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with dipivefrin.


The risk or severity of adverse effects can be increased when Etomidate is combined with Difenoxin.


The risk or severity of adverse effects can be increased when reserpine is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with dexamethasone.


The risk or severity of adverse effects can be increased when ketoprofen is combined with Tixocortol.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with Retigabine.


The risk or severity of adverse effects can be increased when Pipamperone is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when fexofenadine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when ANISOTROPINE METHYLBROMIDE is combined with butorphanol.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with tiagabine.


The risk or severity of adverse effects can be increased when diflunisal is combined with meclofenamic acid.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with ondansetron.


The risk or severity of adverse effects can be increased when thiothixene is combined with Olopatadine.


The risk or severity of adverse effects can be increased when clorazepate is combined with etizolam.


The risk or severity of adverse effects can be increased when Lercanidipine is combined with Rotigotine.


The risk or severity of adverse effects can be increased when secobarbital is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when Treprostinil is combined with celecoxib.


The risk or severity of adverse effects can be increased when primidone is combined with pentobarbital.


The risk or severity of adverse effects can be increased when diflunisal is combined with Icatibant.


The risk or severity of adverse effects can be increased when tiapride is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with HYDROCODONE.


The risk or severity of adverse effects can be increased when HEROIN is combined with tetracaine.


The risk or severity of adverse effects can be increased when enflurane is combined with clidinium.


The risk or severity of adverse effects can be increased when cyclosporin A is combined with cinnarizine.


The risk or severity of adverse effects can be increased when amphotericin b is combined with deslanoside.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with salicylic acid.


The risk or severity of adverse effects can be increased when thioridazine is combined with Bretylium.


The risk or severity of adverse effects can be increased when tolmetin is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when lorazepam is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when reserpine is combined with Clevidipine.


The risk or severity of adverse effects can be increased when morphine is combined with oxycodone.


The risk or severity of adverse effects can be increased when morphine is combined with buspirone.


The risk or severity of adverse effects can be increased when Articaine is combined with felbamate.


The risk or severity of adverse effects can be increased when morphine is combined with fosinopril.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with gabapentin.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with triamcinolone.


The risk or severity of adverse effects can be increased when clonidine is combined with flunarizine.


The risk or severity of adverse effects can be increased when Lorcaserin is combined with Pipamperone.


The risk or severity of adverse effects can be increased when clonidine is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when trazodone is combined with Butethal.


The risk or severity of adverse effects can be increased when trazodone is combined with lithium ion.


The risk or severity of adverse effects can be increased when trazodone is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when cocaine is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with dexamethasone.


The risk or severity of adverse effects can be increased when nabumetone is combined with nimesulide.


The risk or severity of adverse effects can be increased when Rufinamide is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when pargyline is combined with hydromorphone.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with amitriptyline.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with Tolcapone.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when Vilazodone is combined with ACETOPHENAZINE.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Retigabine.


The risk or severity of adverse effects can be increased when Dehydroepiandrosterone is combined with LEVOFLOXACIN.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with nabumetone.


The risk or severity of adverse effects can be increased when Vilazodone is combined with promethazine.


The risk or severity of adverse effects can be increased when Conivaptan is combined with Enalaprilat.


The risk or severity of adverse effects can be increased when BECLOMETHASONE DIPROPIONATE is combined with physostigmine.


The risk or severity of adverse effects can be increased when Dehydroepiandrosterone is combined with donepezil.


The risk or severity of adverse effects can be increased when pentosan polysulfate is combined with anagrelide.


The risk or severity of adverse effects can be increased when BECLOMETHASONE DIPROPIONATE is combined with rivastigmine.


The risk or severity of adverse effects can be increased when disulfiram is combined with sertraline.


The risk or severity of adverse effects can be increased when Olsalazine is combined with dorzolamide.


The risk or severity of adverse effects can be increased when brotizolam is combined with levodopa.


The risk or severity of adverse effects can be increased when PIPECURONIUM is combined with meperidine.


The risk or severity of adverse effects can be increased when temazepam is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Gallium nitrate.


The risk or severity of adverse effects can be increased when quazepam is combined with Tolcapone.


The risk or severity of adverse effects can be increased when nitroglycerin is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when docetaxel is combined with IMIQUIMOD.


The risk or severity of adverse effects can be increased when Telmisartan is combined with mycophenolate mofetil.


The risk or severity of adverse effects can be increased when suprofen is combined with resveratrol.


The risk or severity of adverse effects can be increased when chloroquine is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when BECLOMETHASONE DIPROPIONATE is combined with galanthamine.


The risk or severity of adverse effects can be increased when Asenapine is combined with clidinium.


The risk or severity of adverse effects can be increased when Fospropofol is combined with zonisamide.


The risk or severity of adverse effects can be increased when Fospropofol is combined with tiagabine.


The risk or severity of adverse effects can be increased when aspirin is combined with acetazolamide.


The risk or severity of adverse effects can be increased when nortriptyline is combined with meclizine.


The risk or severity of adverse effects can be increased when enalapril is combined with labetalol.


The risk or severity of adverse effects can be increased when cabergoline is combined with cocaine.


The risk or severity of adverse effects can be increased when enalapril is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when niflumic acid is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when methylergonovine is combined with ambroxol.


The risk or severity of adverse effects can be increased when enalapril is combined with doxazosin.


The risk or severity of adverse effects can be increased when rizatriptan is combined with lithium ion.


The risk or severity of adverse effects can be increased when furosemide is combined with lisinopril.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when furosemide is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when butorphanol is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when Paliperidone is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when butorphanol is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when levorphanol is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when azelastine is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when Vilazodone is combined with methadone.


The risk or severity of adverse effects can be increased when Vilazodone is combined with olanzapine.


The risk or severity of adverse effects can be increased when imipramine is combined with Escitalopram.


The risk or severity of adverse effects can be increased when hydrocortisone is combined with tubocurarine.


The risk or severity of adverse effects can be increased when hydromorphone is combined with flunarizine.


The risk or severity of adverse effects can be increased when ketorolac is combined with Tixocortol.


The risk or severity of adverse effects can be increased when mepivacaine is combined with nefazodone.


The risk or severity of adverse effects can be increased when thiamylal is combined with methocarbamol.


The risk or severity of adverse effects can be increased when nimesulide is combined with flumethasone.


The risk or severity of adverse effects can be increased when hydromorphone is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when thiamylal is combined with triprolidine.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when nalbuphine is combined with promethazine.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with lisinopril.


The risk or severity of adverse effects can be increased when ethotoin is combined with flunarizine.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with Perospirone.


The risk or severity of adverse effects can be increased when isoflurane is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when clindamycin is combined with atorvastatin.


The risk or severity of adverse effects can be increased when GALLAMINE TRIETHIODIDE is combined with orphenadrine.


The risk or severity of adverse effects can be increased when fludrocortisone is combined with galanthamine.


The risk or severity of adverse effects can be increased when fludrocortisone is combined with Isoflurophate.


The risk or severity of adverse effects can be increased when orphenadrine is combined with tubocurarine.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Fospropofol.


The risk or severity of adverse effects can be increased when Bortezomib is combined with oxycodone.


The risk or severity of adverse effects can be increased when fosinopril is combined with mecamylamine.


The risk or severity of adverse effects can be increased when amoxapine is combined with procarbazine.


The risk or severity of adverse effects can be increased when phenobarbital is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when pramipexole is combined with Nebivolol.


The risk or severity of adverse effects can be increased when alprazolam is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when Remoxipride is combined with tetracaine.


The risk or severity of adverse effects can be increased when promazine is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when promazine is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with PAMABROM.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with Perospirone.


The risk or severity of adverse effects can be increased when Sertaconazole is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when thiamylal is combined with carisoprodol.


The risk or severity of adverse effects can be increased when Telmisartan is combined with Bretylium.


The risk or severity of adverse effects can be increased when timolol is combined with penbutolol.


The risk or severity of adverse effects can be increased when Masoprocol is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when nortriptyline is combined with isoproterenol.


The risk or severity of adverse effects can be increased when nortriptyline is combined with ACETOPHENAZINE.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with prazosin.


The risk or severity of adverse effects can be increased when Clevidipine is combined with lovastatin.


The risk or severity of adverse effects can be increased when nortriptyline is combined with promethazine.


The risk or severity of adverse effects can be increased when Masoprocol is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when diazepam is combined with oxazepam.


The risk or severity of adverse effects can be increased when diazepam is combined with nalbuphine.


The risk or severity of adverse effects can be increased when pyridostigmine is combined with acetylcholine.


The risk or severity of adverse effects can be increased when zaleplon is combined with clonazepam.


The risk or severity of adverse effects can be increased when diazepam is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when nevirapine is combined with oxycodone.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Fospropofol.


The risk or severity of adverse effects can be increased when salicylic acid is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with equilin.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when bumetanide is combined with Aliskiren.


The risk or severity of adverse effects can be increased when Salsalate is combined with equilin.


The risk or severity of adverse effects can be increased when BISOPROLOL is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when azelastine is combined with flumethasone.


The risk or severity of adverse effects can be increased when suprofen is combined with meclofenamic acid.


The risk or severity of adverse effects can be increased when prilocaine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when methylergonovine is combined with Tramadol.


The risk or severity of adverse effects can be increased when secobarbital is combined with pentazocine.


The risk or severity of adverse effects can be increased when ethotoin is combined with Difenoxin.


The risk or severity of adverse effects can be increased when suprofen is combined with salicylic acid.


The risk or severity of adverse effects can be increased when cyclopentolate is combined with codeine.


The risk or severity of adverse effects can be increased when tolmetin is combined with Apremilast.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with carisoprodol.


The risk or severity of adverse effects can be increased when AMILORIDE is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when ATROPINE is combined with HEROIN.


The risk or severity of adverse effects can be increased when valsartan is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when Melatonin is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when lidocaine is combined with Normethadone.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when levorphanol is combined with quazepam.


The risk or severity of adverse effects can be increased when CYPROHEPTADINE is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when propoxyphene is combined with trichlormethiazide.


The risk or severity of adverse effects can be increased when CYPROHEPTADINE is combined with Ramelteon.


The risk or severity of adverse effects can be increased when Normethadone is combined with triamterene.


The risk or severity of adverse effects can be increased when propoxyphene is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when tioconazole is combined with eperisone.


The risk or severity of adverse effects can be increased when methylergonovine is combined with teniposide.


The risk or severity of adverse effects can be increased when ketamine is combined with Agomelatine.


The risk or severity of adverse effects can be increased when methylergonovine is combined with chloramphenicol.


The risk or severity of adverse effects can be increased when clemastine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with desipramine.


The risk or severity of adverse effects can be increased when haloprogin is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when nabumetone is combined with suprofen.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with ethotoin.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with tretinoin.


The risk or severity of adverse effects can be increased when Lurasidone is combined with Articaine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Normethadone.


The risk or severity of adverse effects can be increased when Lercanidipine is combined with propofol.


The risk or severity of adverse effects can be increased when bromocriptine is combined with prednisone.


The risk or severity of adverse effects can be increased when bromocriptine is combined with astemizole.


The risk or severity of adverse effects can be increased when bromocriptine is combined with Clofarabine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when pentazocine is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when prazosin is combined with cilazapril.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with tetracaine.


The risk or severity of adverse effects can be increased when leflunomide is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when tetracaine is combined with tiapride.


The risk or severity of adverse effects can be increased when zotepine is combined with carisoprodol.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with Droxicam.


The risk or severity of adverse effects can be increased when moclobemide is combined with ritodrine.


The risk or severity of adverse effects can be increased when Pipamperone is combined with D-mannitol.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with clonidine.


The risk or severity of adverse effects can be increased when Pipamperone is combined with scopolamine.


The risk or severity of adverse effects can be increased when olanzapine is combined with felbamate.


The risk or severity of adverse effects can be increased when loxapine is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when isoflurane is combined with clidinium.


The risk or severity of adverse effects can be increased when Lurasidone is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when timolol is combined with Clevidipine.


The risk or severity of adverse effects can be increased when Lurasidone is combined with oxprenolol.


The risk or severity of adverse effects can be increased when valsartan is combined with cilazapril.


The risk or severity of adverse effects can be increased when lisinopril is combined with papaverine.


The risk or severity of adverse effects can be increased when Lurasidone is combined with prazepam.


The risk or severity of adverse effects can be increased when levorphanol is combined with propoxyphene.


The risk or severity of adverse effects can be increased when anagrelide is combined with aspirin.


The risk or severity of adverse effects can be increased when levorphanol is combined with dyclonine.


The risk or severity of adverse effects can be increased when lisinopril is combined with nifedipine.


The risk or severity of adverse effects can be increased when Arotinolol is combined with halothane.


The risk or severity of adverse effects can be increased when Arotinolol is combined with Bretylium.


The risk or severity of adverse effects can be increased when tenoxicam is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when ATROPINE is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when amifostine is combined with Clevidipine.


The risk or severity of adverse effects can be increased when lorazepam is combined with duloxetine.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with IDARUBICIN.


The risk or severity of adverse effects can be increased when apomorphine is combined with propofol.


The risk or severity of adverse effects can be increased when sulindac is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when salicylamide is combined with dexamethasone.


The risk or severity of adverse effects can be increased when Boceprevir is combined with Abemaciclib.


The risk or severity of adverse effects can be increased when ethosuximide is combined with clidinium.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with enalapril.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with clidinium.


The risk or severity of adverse effects can be increased when metoprolol is combined with trandolapril.


The risk or severity of adverse effects can be increased when Bortezomib is combined with methyldopa.


The risk or severity of adverse effects can be increased when nimesulide is combined with equilin.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when glutethimide is combined with Tolcapone.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Normethadone.


The risk or severity of adverse effects can be increased when glutethimide is combined with amitriptyline.


The risk or severity of adverse effects can be increased when thiamylal is combined with Milnacipran.


The risk or severity of adverse effects can be increased when Bortezomib is combined with apraclonidine.


The risk or severity of adverse effects can be increased when Flupentixol is combined with glutethimide.


The risk or severity of adverse effects can be increased when Bortezomib is combined with Telmisartan.


The risk or severity of adverse effects can be increased when ibuprofen is combined with niflumic acid.


The risk or severity of adverse effects can be increased when ketamine is combined with Melatonin.


The risk or severity of adverse effects can be increased when ketamine is combined with clonazepam.


The risk or severity of adverse effects can be increased when ketamine is combined with promethazine.


The risk or severity of adverse effects can be increased when Lurasidone is combined with baclofen.


The risk or severity of adverse effects can be increased when Spirapril is combined with chloroquine.


The risk or severity of adverse effects can be increased when Pirlindole is combined with Arformoterol.


The risk or severity of adverse effects can be increased when Desloratadine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when doxylamine is combined with nefazodone.


The risk or severity of adverse effects can be increased when midazolam is combined with levorphanol.


The risk or severity of adverse effects can be increased when ipratropium is combined with orphenadrine.


The risk or severity of adverse effects can be increased when Spirapril is combined with sulindac.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with paroxetine.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when mesoridazine is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when metolazone is combined with digoxin.


The risk or severity of adverse effects can be increased when metolazone is combined with sulpiride.


The risk or severity of adverse effects can be increased when carvedilol is combined with cilazapril.


The risk or severity of adverse effects can be increased when nilvadipine is combined with apraclonidine.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when triazolam is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when Olmesartan is combined with Apremilast.


The risk or severity of adverse effects can be increased when triazolam is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when Icatibant is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when Normethadone is combined with procarbazine.


The risk or severity of adverse effects can be increased when Butethal is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when carprofen is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when tiapride is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with desipramine.


The risk or severity of adverse effects can be increased when Salsalate is combined with nimesulide.


The risk or severity of adverse effects can be increased when procaine is combined with topiramate.


The risk or severity of adverse effects can be increased when hydromorphone is combined with olanzapine.


The risk or severity of adverse effects can be increased when tolterodine is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when risperidone is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when risperidone is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when chlormezanone is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when trandolapril is combined with azelastine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with fosinopril.


The risk or severity of adverse effects can be increased when mepivacaine is combined with tetracaine.


The risk or severity of adverse effects can be increased when carisoprodol is combined with dantrolene.


The risk or severity of adverse effects can be increased when medrysone is combined with Gemifloxacin.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when loxapine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when mesoridazine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when butorphanol is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when trandolapril is combined with ketoprofen.


The risk or severity of adverse effects can be increased when lidocaine is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with METAXALONE.


The risk or severity of adverse effects can be increased when bepridil is combined with nitric oxide.


The risk or severity of adverse effects can be increased when penbutolol is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when tioconazole is combined with isradipine.


The risk or severity of adverse effects can be increased when maprotiline is combined with clomipramine.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with sulfasalazine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with trimipramine.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with equilin.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with lisinopril.


The risk or severity of adverse effects can be increased when bromocriptine is combined with Aliskiren.


The risk or severity of adverse effects can be increased when resveratrol is combined with alclofenac.


The risk or severity of adverse effects can be increased when flurazepam is combined with pimozide.


The risk or severity of adverse effects can be increased when pentamidine is combined with nisoldipine.


The risk or severity of adverse effects can be increased when flurazepam is combined with sertraline.


The risk or severity of adverse effects can be increased when BENZYDAMINE is combined with budesonide.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with ketorolac.


The risk or severity of adverse effects can be increased when Eplerenone is combined with acebutolol.


The risk or severity of adverse effects can be increased when tubocurarine is combined with Butylscopolamine.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with nabumetone.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when Halobetasol is combined with ambenonium.


The risk or severity of adverse effects can be increased when nitrazepam is combined with mesoridazine.


The risk or severity of adverse effects can be increased when Etomidate is combined with clidinium.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with tenoxicam.


The risk or severity of adverse effects can be increased when nitrazepam is combined with maprotiline.


The risk or severity of adverse effects can be increased when venlafaxine is combined with ACENOCOUMAROL.


The risk or severity of adverse effects can be increased when nalbuphine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when butamben is combined with Iloperidone.


The risk or severity of adverse effects can be increased when MELPERONE is combined with carisoprodol.


The risk or severity of adverse effects can be increased when oxycodone is combined with protriptyline.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with paramethasone.


The risk or severity of adverse effects can be increased when meperidine is combined with QUINETHAZONE.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when Halobetasol is combined with tubocurarine.


The risk or severity of adverse effects can be increased when flurazepam is combined with tiapride.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with fluoxetine.


The risk or severity of adverse effects can be increased when amisulpride is combined with Retigabine.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with levorphanol.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with duloxetine.


The risk or severity of adverse effects can be increased when Tavaborole is combined with bepridil.


The risk or severity of adverse effects can be increased when Desloratadine is combined with sertraline.


The risk or severity of adverse effects can be increased when diclofenac is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when mesoridazine is combined with clidinium.


The risk or severity of adverse effects can be increased when halothane is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when halothane is combined with flunarizine.


The risk or severity of adverse effects can be increased when Fesoterodine is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when oxprenolol is combined with Desloratadine.


The risk or severity of adverse effects can be increased when oxprenolol is combined with apraclonidine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with DESFLURANE.


The risk or severity of adverse effects can be increased when dibucaine is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when dibucaine is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when ropinirole is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when butabarbital is combined with propofol.


The risk or severity of adverse effects can be increased when Phenelzine is combined with bupropion.


The risk or severity of adverse effects can be increased when apomorphine is combined with triamterene.


The risk or severity of adverse effects can be increased when terbutaline is combined with hydroxyamphetamine.


The risk or severity of adverse effects can be increased when amisulpride is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when timolol is combined with triamterene.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with alclofenac.


The risk or severity of adverse effects can be increased when temazepam is combined with ondansetron.


The risk or severity of adverse effects can be increased when temazepam is combined with tiagabine.


The risk or severity of adverse effects can be increased when temazepam is combined with cocaine.


The risk or severity of adverse effects can be increased when gabapentin is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when pentamidine is combined with gabapentin.


The risk or severity of adverse effects can be increased when carbamazepine is combined with mesoridazine.


The risk or severity of adverse effects can be increased when carbamazepine is combined with maprotiline.


The risk or severity of adverse effects can be increased when temazepam is combined with zonisamide.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with HEROIN.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with Asenapine.


The risk or severity of adverse effects can be increased when triamcinolone is combined with Isoflurophate.


The risk or severity of adverse effects can be increased when morphine is combined with METAXALONE.


The risk or severity of adverse effects can be increased when mesoridazine is combined with etizolam.


The risk or severity of adverse effects can be increased when pergolide is combined with Iloperidone.


The risk or severity of adverse effects can be increased when Trometamol is combined with misoprostol.


The risk or severity of adverse effects can be increased when TETRABENAZINE is combined with Remoxipride.


The risk or severity of adverse effects can be increased when TETRABENAZINE is combined with loxapine.


The risk or severity of adverse effects can be increased when Rotigotine is combined with prazosin.


The risk or severity of adverse effects can be increased when Tixocortol is combined with decamethonium.


The risk or severity of adverse effects can be increased when irbesartan is combined with Spirapril.


The risk or severity of adverse effects can be increased when pergolide is combined with sulfamethoxazole.


The risk or severity of adverse effects can be increased when Phenelzine is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with topiramate.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with clonidine.


The risk or severity of adverse effects can be increased when Clofarabine is combined with methyldopa.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with venlafaxine.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when triflupromazine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when NATAMYCIN is combined with nitrendipine.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with clonazepam.


The risk or severity of adverse effects can be increased when dextroamphetamine is combined with selegiline.


The risk or severity of adverse effects can be increased when betaxolol is combined with methazolamide.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when sotalol is combined with methazolamide.


The risk or severity of adverse effects can be increased when isradipine is combined with Eprosartan.


The risk or severity of adverse effects can be increased when pergolide is combined with metyrapone.


The risk or severity of adverse effects can be increased when alclofenac is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when methadone is combined with Agomelatine.


The risk or severity of adverse effects can be increased when difluprednate is combined with sparfloxacin.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when pentamidine is combined with xylometazoline.


The risk or severity of adverse effects can be increased when Micafungin is combined with gabapentin.


The risk or severity of adverse effects can be increased when methazolamide is combined with quinapril.


The risk or severity of adverse effects can be increased when methazolamide is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when methazolamide is combined with bumetanide.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when Desloratadine is combined with topiramate.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with clomipramine.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Icatibant.


The risk or severity of adverse effects can be increased when proparacaine is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when morphine is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when acemetacin is combined with flumethasone.


The risk or severity of adverse effects can be increased when rasagiline is combined with methazolamide.


The risk or severity of adverse effects can be increased when oxybutynin is combined with oxycodone.


The risk or severity of adverse effects can be increased when hydromorphone is combined with Efonidipine.


The risk or severity of adverse effects can be increased when oxymetazoline is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with thiopental.


The risk or severity of adverse effects can be increased when salicylamide is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when methylene blue is combined with terbutaline.


The risk or severity of adverse effects can be increased when salicylic acid is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with cocaine.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with betamethasone.


The risk or severity of adverse effects can be increased when Tavaborole is combined with nicardipine.


The risk or severity of adverse effects can be increased when ACENOCOUMAROL is combined with Nintedanib.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when CICLOPIROX is combined with flunarizine.


The risk or severity of adverse effects can be increased when butabarbital is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with Milnacipran.


The risk or severity of adverse effects can be increased when butabarbital is combined with diphenhydramine.


The risk or severity of adverse effects can be increased when CYCLIZINE is combined with Difenoxin.


The risk or severity of adverse effects can be increased when Olopatadine is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when Olopatadine is combined with Retigabine.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with Pizotifen.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with ethotoin.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with tretinoin.


The risk or severity of adverse effects can be increased when diclofenac is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with prilocaine.


The risk or severity of adverse effects can be increased when doxazosin is combined with irbesartan.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when doxazosin is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when doxazosin is combined with felodipine.


The risk or severity of adverse effects can be increased when Toloxatone is combined with apraclonidine.


The risk or severity of adverse effects can be increased when cabergoline is combined with colchicine.


The risk or severity of adverse effects can be increased when clozapine is combined with Lofexidine.


The risk or severity of adverse effects can be increased when Mometasone is combined with sparfloxacin.


The risk or severity of adverse effects can be increased when meperidine is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when triflupromazine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when Pregabalin is combined with atorvastatin.


The risk or severity of adverse effects can be increased when valsartan is combined with fenoprofen.


The risk or severity of adverse effects can be increased when PIPECURONIUM is combined with morphine.


The risk or severity of adverse effects can be increased when secobarbital is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when nicergoline is combined with rivastigmine.


The risk or severity of adverse effects can be increased when terconazole is combined with flunarizine.


The risk or severity of adverse effects can be increased when enflurane is combined with clonidine.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when nicergoline is combined with risperidone.


The risk or severity of adverse effects can be increased when bifonazole is combined with cilnidipine.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with Iloperidone.


The risk or severity of adverse effects can be increased when morphine is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when nitroglycerin is combined with nadolol.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with Naftifine.


The risk or severity of adverse effects can be increased when imipramine is combined with metaproterenol.


The risk or severity of adverse effects can be increased when pentazocine is combined with clonidine.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with flumethasone.


The risk or severity of adverse effects can be increased when CARTEOLOL is combined with methazolamide.


The risk or severity of adverse effects can be increased when CARTEOLOL is combined with Eplerenone.


The risk or severity of adverse effects can be increased when rasagiline is combined with Levalbuterol.


The risk or severity of adverse effects can be increased when benazepril is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when DESONIDE is combined with NICORANDIL.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with methadone.


The risk or severity of adverse effects can be increased when Butylscopolamine is combined with Mirabegron.


The risk or severity of adverse effects can be increased when propranolol is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when butamben is combined with levodopa.


The risk or severity of adverse effects can be increased when Eprosartan is combined with dipyridamole.


The risk or severity of adverse effects can be increased when trazodone is combined with halothane.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with NAPROXEN.


The risk or severity of adverse effects can be increased when ethopropazine is combined with levorphanol.


The risk or severity of adverse effects can be increased when chloroquine is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when zaleplon is combined with citalopram.


The risk or severity of adverse effects can be increased when Flupentixol is combined with tetracaine.


The risk or severity of adverse effects can be increased when enflurane is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when methylergonovine is combined with mitoxantrone.


The risk or severity of adverse effects can be increased when ketoprofen is combined with Halobetasol.


The risk or severity of adverse effects can be increased when trazodone is combined with Etidocaine.


The risk or severity of adverse effects can be increased when butamben is combined with trimipramine.


The risk or severity of adverse effects can be increased when Flibanserin is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when ketoprofen is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when linezolid is combined with reserpine.


The risk or severity of adverse effects can be increased when LISURIDE is combined with buprenorphine.


The risk or severity of adverse effects can be increased when methylergonovine is combined with lomustine.


The risk or severity of adverse effects can be increased when barnidipine is combined with Nebivolol.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with bicalutamide.


The risk or severity of adverse effects can be increased when benzoic acid is combined with PERHEXILINE.


The risk or severity of adverse effects can be increased when phenobarbital is combined with clidinium.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with meclizine.


The risk or severity of adverse effects can be increased when protriptyline is combined with Lorcaserin.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with trazodone.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with brimonidine.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when nicergoline is combined with vinorelbine.


The risk or severity of adverse effects can be increased when meprobamate is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when Sacubitril is combined with nifedipine.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with sotalol.


The risk or severity of adverse effects can be increased when Sacubitril is combined with papaverine.


The risk or severity of adverse effects can be increased when tretinoin is combined with clonidine.


The risk or severity of adverse effects can be increased when cabergoline is combined with sulfanilamide.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when quazepam is combined with dibucaine.


The risk or severity of adverse effects can be increased when phenylpropanolamine is combined with hydroxyamphetamine.


The risk or severity of adverse effects can be increased when chlormezanone is combined with desipramine.


The risk or severity of adverse effects can be increased when Pramocaine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when Vilazodone is combined with protriptyline.


The risk or severity of adverse effects can be increased when CICLOPIROX is combined with cinnarizine.


The risk or severity of adverse effects can be increased when triflupromazine is combined with methocarbamol.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with halothane.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Bretylium.


The risk or severity of adverse effects can be increased when triflupromazine is combined with triprolidine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with thiamylal.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when nitrazepam is combined with citalopram.


The risk or severity of adverse effects can be increased when selegiline is combined with ARBUTAMINE.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with triflupromazine.


The risk or severity of adverse effects can be increased when cyclosporin A is combined with nitrendipine.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with triazolam.


The risk or severity of adverse effects can be increased when butorphanol is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when tretinoin is combined with captopril.


The risk or severity of adverse effects can be increased when meperidine is combined with ethosuximide.


The risk or severity of adverse effects can be increased when epirizole is combined with DESONIDE.


The risk or severity of adverse effects can be increased when tretinoin is combined with acebutolol.


The risk or severity of adverse effects can be increased when mirtazapine is combined with Escitalopram.


The risk or severity of adverse effects can be increased when Atracurium besylate is combined with orphenadrine.


The risk or severity of adverse effects can be increased when mesalamine is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when zopiclone is combined with Retigabine.


The risk or severity of adverse effects can be increased when methadone is combined with dextromethorphan.


The risk or severity of adverse effects can be increased when nitrendipine is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when gabapentin is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when Cilastatin is combined with Temsirolimus.


The risk or severity of adverse effects can be increased when celecoxib is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with Tixocortol.


The risk or severity of adverse effects can be increased when phenytoin is combined with tizanidine.


The risk or severity of adverse effects can be increased when desipramine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when celecoxib is combined with acemetacin.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when Retigabine is combined with venlafaxine.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when tretinoin is combined with quetiapine.


The risk or severity of adverse effects can be increased when flunarizine is combined with Escitalopram.


The risk or severity of adverse effects can be increased when Remoxipride is combined with ethosuximide.


The risk or severity of adverse effects can be increased when niflumic acid is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with atorvastatin.


The risk or severity of adverse effects can be increased when niflumic acid is combined with formestane.


The risk or severity of adverse effects can be increased when benzocaine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when Remoxipride is combined with thiopental.


The risk or severity of adverse effects can be increased when antipyrine is combined with formestane.


The risk or severity of adverse effects can be increased when antipyrine is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when venlafaxine is combined with loxapine.


The risk or severity of adverse effects can be increased when prazosin is combined with clonidine.


The risk or severity of adverse effects can be increased when benazepril is combined with nadolol.


The risk or severity of adverse effects can be increased when olanzapine is combined with meperidine.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with MELPERONE.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with zotepine.


The risk or severity of adverse effects can be increased when trazodone is combined with desipramine.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when chloroxine is combined with xylometazoline.


The risk or severity of adverse effects can be increased when Sacubitril is combined with tolazoline.


The risk or severity of adverse effects can be increased when Sacubitril is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when Sacubitril is combined with sulfasalazine.


The risk or severity of adverse effects can be increased when Carbetocin is combined with spironolactone.


The risk or severity of adverse effects can be increased when nalbuphine is combined with mepivacaine.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with Droxicam.


The risk or severity of adverse effects can be increased when Clofarabine is combined with Aliskiren.


The risk or severity of adverse effects can be increased when trazodone is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when Nabilone is combined with dipyridamole.


The risk or severity of adverse effects can be increased when Escitalopram is combined with AMPHETAMINE.


The risk or severity of adverse effects can be increased when trimipramine is combined with levodopa.


The risk or severity of adverse effects can be increased when diflunisal is combined with oxaprozin.


The risk or severity of adverse effects can be increased when oxaprozin is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with sulindac.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with cetirizine.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with triflupromazine.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with betamethasone.


The risk or severity of adverse effects can be increased when Etidocaine is combined with flunarizine.


The risk or severity of adverse effects can be increased when methyldopa is combined with Clevidipine.